Hormonal therapies in migraine management: current perspectives on patient selection and risk management

References

• Sutherland HG, Albury CL, Griffiths LR. Advances in genetics of migraine. J Headache Pain. 2019Jun21;20(1):72. PMID: 31226929; PMCID: PMC6734342.
   PubMed Web of Science ®Google Scholar
• Arzani M, Jahromi SR, Ghorbani Z, et al. School of Advanced Studies of the European Headache Federation (EHF-SAS). gut-brain axis and migraine headache: a comprehensive review. J Headache Pain. 2020Feb13;21(1):15. PMID: 32054443; PMCID: PMC7020496.
   PubMed Web of Science ®Google Scholar
• Link AS, Kuris A, Edvinsson L. Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system. J Headache Pain. 2008Feb9;9(1):5–12. Epub 2008 Jan 23. PMID: 18217201; PMCID: PMC2245994.
   PubMed Web of Science ®Google Scholar
• Delaruelle Z, Ivanova TA, Khan S, et al. European Headache Federation School of Advanced Studies (EHF-SAS). Male and female sex hormones in primary headaches. J Headache Pain. 2018Nov29;19(1):117. PMID: 30497379; PMCID: PMC6755575.
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS, Caveng N, Speiermann G, et al. Migraine start, course and features over the cycle of combined hormonal contraceptive users with menstrual migraine - temporal relation to bleeding and hormone withdrawal: a prospective diary-based study. J Headache Pain. 2020Jun24;21(1):81. PMID: 32580694; PMCID: PMC7315546.
   PubMed Web of Science ®Google Scholar
• Sacco S, Merki-Feld GS, Ægidius KL, et al. European Headache Federation (EHF), the European Society of Contraception and Reproductive Health (ESCRH). Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH). J Headache Pain. 2018Aug31;19(1):76. PMID: 30171365; PMCID: PMC6119173.
   PubMed Web of Science ®Google Scholar
• Labastida-Ramírez A, Rubio-Beltrán E, Villalón CM, et al. Gender aspects of CGRP in migraine. Cephalalgia. 2019Mar;39(3):435–444. Epub 2017 Oct 30. PMID: 29082826; PMCID: PMC6402050
   PubMed Web of Science ®Google Scholar
• Bustamante-Barrientos FA, Méndez-Ruette M, Ortloff, et al. the impact of estrogen and estrogen-like molecules in neurogenesis and neurodegeneration: beneficial or harmful? Front Cell Neurosci. 2021 Mar 8;15:636176. PMID: 33762910; PMCID: PMC7984366.
   PubMed Web of Science ®Google Scholar
• Maleki N, Linnman C, Brawn J, et al. Her versus his migraine: multiple sex differences in brain function and structure. Brain. 2012Aug;135(8):2546–2559. PMID: 22843414; PMCID: PMC3407427.
   PubMed Web of Science ®Google Scholar
• Afridi SK. Migraine: navigating the hormonal minefield. Pract Neurol. 2020Apr;20(2):115–121. Epub 2019 Nov 21. PMID: 31753858.
   PubMedGoogle Scholar
• MacGregor EA. Migraine, menopause and hormone replacement therapy. Post Reprod Health. 2018Mar;24(1):11–18. Epub 2017 Oct 10. PMID: 28994639.
   PubMedGoogle Scholar
• Bentivegna E, Luciani M, Paragliola V, et al. Recent advancements in tension-type headache: a narrative review. Expert Rev Neurother. Jul 2 2021;1–11. Epub ahead of print. PMID: 34128449 https://doi.org/10.1080/14737175.2021.1943363
   Google Scholar
• Ashina S, Bentivegna E, Martelletti P, et al. Structural and functional brain changes in migraine. Pain Ther. 2021Jun;10(1):211–223. Epub 2021 Feb 16. PMID: 33594593; PMCID: PMC8119592
   PubMed Web of Science ®Google Scholar
• Skorobogatykh K, van Hoogstraten WS, Degan D, et al. European Headache Federation School of Advanced Studies (EHF-SAS). functional connectivity studies in migraine: what have we learned? J Headache Pain. 2019Nov20;20(1):108. PMID: 31747874; PMCID: PMC6868768.
   PubMed Web of Science ®Google Scholar
• Hasan H, Irfan Waheed R, Bin Arif T, et al. Gray and white matter changes in migraineurs: a review of literature. SN Compr Clin Med. 2020;2(11):2185–2196.
   Google Scholar
• Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA. 2006 Apr 19;295(15):1824–1830. PMID: 16622144.
   PubMed Web of Science ®Google Scholar
• Borsook D, Erpelding N, Lebel A, et al. Sex and the migraine brain. Neurobiol Dis. 2014 Aug;68:200–214. Epub 2014 Mar 21. PMID: 24662368; PMCID: PMC4171725.
   PubMed Web of Science ®Google Scholar
• Ashina M, Terwindt GM, Al-Karagholi MA, et al. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet. 2021Apr17;397(10283):1496–1504. Epub 2021 Mar 25. PMID: 33773610.
   PubMed Web of Science ®Google Scholar
• Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis–part I. Headache. 2006Jan;46(1):3–23. PMID: 16412147.
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Estrogen replacement and migraine. Maturitas. 2009May20;63(1):51–55. Epub 2009 Apr 16. PMID: 19375252.
   PubMed Web of Science ®Google Scholar
• Macìas G, Merki-Feld GS, Parke S, et al. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study. J Obstet Gynaecol. 2013Aug;33(6):591–596. PMID: 23919857.
   PubMedGoogle Scholar
• Nappi RE, Terreno E, Sances G, et al. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM). Contraception. 2013Sep;88(3):369–375. Epub 2013 Feb 28 PMID: 23453784.
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Lin H, et al. Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol. 2008Jan;111(1):127–136. PMID: 18165401.
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson , JE, and Colditz, GA, et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000Dec19;133(12):933–941. PMID: 11119394.
   PubMed Web of Science ®Google Scholar
• Vetvik KG, MacGregor EA. Menstrual migraine: a distinct disorder needing greater recognition. Lancet Neurol. 2021Apr;20(4):304–315. Epub 2021 Feb 15. PMID: 33600767.
   PubMed Web of Science ®Google Scholar
• Cupini LM, Corbelli I, Sarchelli P. Menstrual migraine: what it is and does it matter? J Neurol. 2021Jul;268(7):2355–2363. Epub 2020 Jan 28. PMID: 31989282.
   PubMed Web of Science ®Google Scholar
• Reddy N, Desai MN, Schoenbrunner A, et al. The complex relationship between estrogen and migraines: a scoping review. Syst Rev. 2021Mar10;10(1):72. PMID: 33691790; PMCID: PMC7948327.
   PubMed Web of Science ®Google Scholar
• Krause DN, Duckles SP, Pelligrino DA. Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol (1985). 2006Oct;101(4):1252–1261. Epub 2006 Jun 22. PMID: 16794020.
   PubMed Web of Science ®Google Scholar
• Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev. 2008 Jun;60(2):210–241.
   PubMed Web of Science ®Google Scholar
• Chauvel V, Multon S, Schoenen J. Estrogen-dependent effects of 5-hydroxytryptophan on cortical spreading depression in rat: modelling the serotonin-ovarian hormone interaction in migraine aura. Cephalalgia. 2018Mar;38(3):427–436. Epub 2017 Feb 1. PMID: 28145727.
   PubMed Web of Science ®Google Scholar
• Gupta S, McCarson KE, Welch KM, et al. Mechanisms of pain modulation by sex hormones in migraine. Headache. 2011Jun;51(6):905–922. PMID: 21631476
   PubMed Web of Science ®Google Scholar
• Pavlovic JM, Akcali D, Bolay H, et al. Sex-related influences in migraine. J Neurosci Res. 2017Jan2;95(1–2):587–593. PMID: 27870430.
   PubMed Web of Science ®Google Scholar
• Gruber CJ, Huber JC. Differential effects of progestins on the brain. Maturitas. 2003Dec10;46(Suppl 1):S71–5. PMID: 14670648.
   PubMed Web of Science ®Google Scholar
• De Matteis E, Guglielmetti M, Ornello R, et al. Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives. Expert Rev Neurother. 2020Jun;20(6):627–641. Epub 2020 Jun 2. PMID: 32434430
   PubMed Web of Science ®Google Scholar
• Favoni V, Giani L, Al-Hassany L, et al. European Headache Federation School of Advanced Studies (EHF-SAS). CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP? J Headache Pain. 2019Mar12;20(1):27. PMID: 30866804; PMCID: PMC6734543.
   PubMed Web of Science ®Google Scholar
• Capi M, De Angelis V, De Bernardini D, et al. CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine. J Clin Med. 2021Apr1;10(7):1429. PMID: 33916043; PMCID: PMC8038117.
   PubMed Web of Science ®Google Scholar
• Spuntarelli V, Negro A, Luciani M, et al. Eptinezumab for the treatment of migraine. Expert Opin Biol Ther. Jun 1 2021;1–13. Epub ahead of print. PMID: 34009094 https://doi.org/10.1080/14712598.2021.1931678
   Google Scholar
• Liu T, Shi F, Ying Y, et al. Mouse model of menstruation: an indispensable tool to investigate the mechanisms of menstruation and gynaecological diseases (Review). Mol Med Rep. 2020Dec;22(6):4463–4474. Epub 2020 Oct 7. PMID: 33174022; PMCID: PMC7646730.
   PubMed Web of Science ®Google Scholar
• Gupta S, Villalón CM, Mehrotra S, et al. Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin. Headache. 2007Feb;47(2):225–235. PMID: 17300362.
   PubMed Web of Science ®Google Scholar
• Antonova M, Wienecke T, Olesen J, et al. Prostaglandin E(2) induces immediate migraine-like attack in migraine patients without aura. Cephalalgia. 2012Aug;32(11):822–833. Epub 2012 Jun 19. PMID: 22718556.
   PubMed Web of Science ®Google Scholar
• Maasumi K, Tepper SJ, Kriegler JS. Menstrual migraine and treatment options: review. Headache. 2017Feb2;57(2):194–208. Epub 2016 Dec 2. PMID: 27910087.
   PubMed Web of Science ®Google Scholar
• Nett R, Mannix LK, Mueller L, et al. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine. Headache. 2008Sep;48(8):1194–1201. Epub 2008 Apr 14. PMID: 18422606.
   PubMed Web of Science ®Google Scholar
• Champaloux SW, Tepper NK, Monsour M, et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol. 2017May;216(5):489.e1–489.e7. Epub 2016 Dec 26. PMID: 28034652.
   PubMed Web of Science ®Google Scholar
• Ansari T, Lagman-Bartolome AM, Monsour D, et al. Management of menstrual migraine. Curr Neurol Neurosci Rep. 2020Aug8;20(10):45. PMID: 32770368.
   PubMed Web of Science ®Google Scholar
• Negro A, Delaruelle Z, Ivanova TA, et al. European Headache Federation School of Advanced Studies (EHF-SAS). Headache and pregnancy: a systematic review. J Headache Pain. 2017Oct19;18(1):106. PMID: 29052046; PMCID: PMC5648730.
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Migraine in pregnancy and lactation. Neurol Sci. 2014May;35(Suppl S1):61–64. PMID: 24867839.
   PubMed Web of Science ®Google Scholar
• Kvisvik EV, Stovner LJ, Helde G, et al. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain. 2011Aug;12(4):443–451. Epub 2011 Mar 26. PMID: 21442333; PMCID: PMC3139061.
   PubMed Web of Science ®Google Scholar
• MacGregor A. Effects of oral and transdermal estrogen replacement on migraine. Cephalalgia. 1999Mar;19(2):124–125. PMID: 10214539.
   PubMed Web of Science ®Google Scholar
• Aegidius KL, Zwart JA, Hagen K, et al. Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur J Neurol. 2007Jan;141:73–78. PMID: 17222117
   PubMed Web of Science ®Google Scholar
• Silberstein SD, de Lignières B. Migraine, menopause and hormonal replacement therapy. Cephalalgia. 2000Apr;20(3):214–221. PMID: 10997776.
   PubMed Web of Science ®Google Scholar
• Kaiser HJ, Meienberg O. Deterioration or onset of migraine under oestrogen replacement therapy in the menopause. J Neurol. 1993;240(3):195–197. PMID: 8482995.
   PubMed Web of Science ®Google Scholar
• Middeldorp S, Meijers JC, van Den Ende AE, et al. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study. Thromb Haemost. 2000 Jul;84(7):4–8. PMID: 10928461.
   PubMed Web of Science ®Google Scholar
• Meijers JC, Middeldorp S, Tekelenburg W, et al. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Thromb Haemost. 2000 Jul;84(7):9–14. PMID: 10928462.
   PubMed Web of Science ®Google Scholar
• Høibraaten E, Qvigstad E, Arnesen H, et al. Increased risk of recurrent venous thromboembolism during hormone replacement therapy–results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Thromb Haemost. 2000 Dec;84(12):961–967. PMID: 11154141.
   PubMed Web of Science ®Google Scholar
• Cushman M, Kuller, LH, and Prentice, R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA. 2004;292(13):1573–1580.
   PubMed Web of Science ®Google Scholar
• Gomes MPV, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med. 2004Oct11;164(18):1965–1976. PMID: 15477430.
   PubMedGoogle Scholar
• Gerstman BB, Piper JM, Tomita DK, et al. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol. 1991Jan;133(1):32–37. PMID: 1983896.
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson JE, Stampfer MJ, et al. Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med. 2008Apr28;168(8):861–866. PMID: 18443262; PMCID: PMC4001717.
   PubMedGoogle Scholar
• Renoux C, Dell’aniello S, Garbe E, et al. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ. 2010Jun3;340(jun03 4):c2519. PMID: 20525678.
   PubMed Web of Science ®Google Scholar
• Bushnell C, McCullough LD, Awad IA, et al. American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council for High Blood Pressure Research. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1545–1588.
   PubMed Web of Science ®Google Scholar
• Weill A, Dalichampt M, Raguideau F, et al. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study. BMJ. 2016 May 10;353:i2002. PMID: 27164970; PMCID: PMC4862376.
   PubMed Web of Science ®Google Scholar
• Carlton C, Banks M, Sundararajan S. Oral contraceptives and ischemic stroke risk. Stroke. 2018Apr;49(4):e157–e159. Epub 2018 Mar 16. PMID: 29581347.
   PubMed Web of Science ®Google Scholar
• MacClellan LR, Giles W, Cole J, et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke. 2007 Sep 9;38:2438–2445. Epub 2007 Aug 9. PMID: 17690308.
   PubMed Web of Science ®Google Scholar
• Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 1996Aug15;335(7):453–461. Erratum in: N Engl J Med 1996 Oct 31;335(18):1406.PMID: 8672166.
   PubMed Web of Science ®Google Scholar
• Mørch LS, Ø L, Keiding N, et al. The influence of hormone therapies on colon and rectal cancer. Eur J Epidemiol. 2016May;31(5):9–14. Epub 2016 Jan 12. PMID: 26758900.
   Web of Science ®Google Scholar
• Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995Jun15;332(24):961–967. PMID: 7753136.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson , GL, and Prentice, RL, et al. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002Jul17;288(3):321–333. PMID: 12117397.
   PubMed Web of Science ®Google Scholar
• Hodis HN, Mack WJ. A “window of opportunity:” the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent. Brain Res. 2011Mar16;1379(1379):244–252. Epub 2010 Oct 25. PMID: 20977895; PMCID: PMC3046231.
   PubMed Web of Science ®Google Scholar
• Gurney EP, Nachtigall MJ, Nachtigall LE, et al. The Women’s Health Initiative trial and related studies: 10 years later: a clinician’s view. J Steroid Biochem Mol Biol. 2014 Jul;142:4–11. Epub 2013 Oct 27. PMID: 24172877.
   PubMed Web of Science ®Google Scholar
• Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012Oct9;345(oct09 2):e6409. PMID: 23048011.
   PubMed Web of Science ®Google Scholar
• Crandall CJ, Hovey KM, Andrews C, et al. Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the women’s health initiative observational study. Menopause. 2017Oct;24(10):1145–1153. PMID: 28697036; PMCID: PMC5607093.
   PubMed Web of Science ®Google Scholar
• Henderson VW, Lobo RA. Hormone therapy and the risk of stroke: perspectives 10 years after the women’s health initiative trials. Climacteric. 2012Jun;15(3):229–234. PMID: 22612608; PMCID: PMC3675220.
   PubMed Web of Science ®Google Scholar
• Chang WC, Wang JH, Ding DC. Conjugated equine estrogen used in postmenopausal women associated with a higher risk of stroke than estradiol. Sci Rep. 2021May24;11(1):10801. PMID: 34031535; PMCID: PMC8144437.
   PubMed Web of Science ®Google Scholar
• Sacco S, Cerone D, Carolei A. Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain. 2008 Aug 9(4;9(4):229–234. Epub 2008 Jul 4. PMID: 18600300; PMCID: PMC3451940.
   Web of Science ®Google Scholar
• Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9–160. PMID: 14979299.
   PubMed Web of Science ®Google Scholar
• Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation collaborative study of cardiovascular disease and steroid hormone contraception. BMJ. 1999Jan2;318(7175):13–18. PMID: 9872876; PMCID: PMC27668.
   PubMed Web of Science ®Google Scholar
• Magalhães JE, Sampaio Rocha-Filho PA. Migraine and cerebrovascular diseases: epidemiology, pathophysiological, and clinical considerations. Headache. 2018Sep;58(8):1277–1286. Epub 2018 Aug 17. PMID: 30117565.
   PubMed Web of Science ®Google Scholar
• Schürks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009Oct27;339(oct27 1):b3914. PMID: 19861375; PMCID: PMC2768778.
   PubMed Web of Science ®Google Scholar
• Etminan M, Takkouche B, Isorna FC, et al. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ. 2005Jan8;330(7482):63. Epub 2004 Dec 13. Erratum in: BMJ. 2005 Feb 12;330(7487):345.Erratum in: BMJ. 2005 Mar 12;330(7491):596.PMID: 15596418; PMCID: PMC543862.
   PubMed Web of Science ®Google Scholar
• Wammes-van der Heijden EA, Tijssen CC, Egberts AC. Right-to-left shunt and migraine: the strength of the relationship. Cephalalgia. 2006Feb;26(2):208–213. PMID: 16426277.
   PubMed Web of Science ®Google Scholar
• Yemisci M, Eikermann-Haerter K. Aura and Stroke: relationship and what we have learnt from preclinical models. J Headache Pain. 2019May29;20(1):63. PMID: 31142262; PMCID: PMC6734247.
   PubMed Web of Science ®Google Scholar
• Eikermann-Haerter K, Yuzawa I, Qin T, et al. Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J Neurosci. 2011Apr13;31(15):5755–5763. PMID: 21490217; PMCID: PMC3135337.
   PubMed Web of Science ®Google Scholar
• Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol. 2010Feb;67(2):221–229. PMID: 20225282; PMCID: PMC2921919
   PubMed Web of Science ®Google Scholar
• Zhang Y, Parikh A, Qian S. Migraine and stroke. Stroke Vasc Neurol. 2017May29;2(3):160–167. PMID: 28989805; PMCID: PMC5628377.
   PubMedGoogle Scholar
• Khennouf L, Gesslein B, Brazhe A, et al. Active role of capillary pericytes during stimulation-induced activity and spreading depolarization. Brain. 2018Jul1;141(7):2032–2046. PMID: 30053174; PMCID: PMC6022680.
   PubMed Web of Science ®Google Scholar
• Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004May;113(10):1447–1455. PMID: 15146242; PMCID: PMC406541.
   PubMed Web of Science ®Google Scholar
• Tsai CL, Chou CH, Lee PJ, et al. The potential impact of primary headache disorders on stroke risk. J Headache Pain. 2016Dec;17(1):108. Epub 2016 Dec 1. PMID: 27905079; PMCID: PMC5130928.
   PubMed Web of Science ®Google Scholar
• Tietjen EG, Tietjen MD. Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications. Cephalalgia. 2007Aug;27(8):981–987. PMID: 17661875.
   PubMed Web of Science ®Google Scholar
• Rajan R, Ahluwalia J, Lal V. Prothrombotic states in migraine. Clin Appl Thromb Hemost. 2014Nov;20(8):851–856. Epub 2013 May 1. PMID: 23637003.
   PubMed Web of Science ®Google Scholar
• Timm FP, Houle TT, Grabitz SD, et al. Migraine and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study. BMJ. 2017 Jan 10;356:i6635. PMID: 28073753; PMCID: PMC5225233.
   PubMed Web of Science ®Google Scholar
• Sacco S, Ornello R, Ripa P, et al. Migraine and hemorrhagic stroke: a meta-analysis. Stroke. 2013Nov;44(11):3032–3038. Epub 2013 Oct 1 PMID: 24085027
   PubMed Web of Science ®Google Scholar
• Gaist D, González-Pérez A, Ashina M, et al. Migraine and risk of hemorrhagic stroke: a study based on data from general practice. J Headache Pain. 2014Nov11;15(1):74. PMID: 25387444; PMCID: PMC4238312.
   PubMed Web of Science ®Google Scholar
• Ornello R, Pistoia F, Degan D, et al. Migraine and hemorrhagic stroke: data from general practice. J Headache Pain. 2015Jan21;16(1):8. PMID: 25609262; PMCID: PMC4405509.
   PubMed Web of Science ®Google Scholar
• Artto V, Wessman M, Nissilä M, et al. Comorbidity in Finnish migraine families. J Headache Pain. 2006Oct7;7(5):324–330. Epub 2006 Oct 25. PMID: 17058048; PMCID: PMC3468175.
   PubMedGoogle Scholar
• Yoon G, Baggaley S, Bacchetti P, et al. Clinic-based study of family history of vascular risk factors and migraine. J Headache Pain. 2005Oct6;6(5):412–416. Epub 2005 Sep 21. PMID: 16362715; PMCID: PMC3452064.
   PubMedGoogle Scholar
• Ross OA, Soto-Ortolaza AI, Heckman MG, et al. NOTCH3 variants and risk of ischemic stroke. PLoS One. 2013Sep23;8(9):e75035. PMID: 24086431; PMCID: PMC3781028.
   PubMed Web of Science ®Google Scholar
• Sacco S, Ricci S, Degan D, et al. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012Apr;133:177–189. Epub 2012 Feb 26. PMID: 22367631; PMCID: PMC3311830.
   PubMed Web of Science ®Google Scholar
• Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA. 2006Jul19;296(3):283–291. Erratum in: JAMA. 2006 Aug 9;296(6):654.Erratum in: JAMA. 2006 Jul 19;296(3):1p following 291. PMID: 16849661.
   PubMed Web of Science ®Google Scholar
• Jacobson JC, Aikins Murphy P. United States medical eligibility criteria for contraceptive use 2010: a review of changes. J Midwifery Womens Health. 2011Nov-Dec;56(6):598–607. Epub 2011 Oct 17. PMID: 22060220.
   PubMed Web of Science ®Google Scholar
• Sacco S, Merki-Feld GS, Ægidius KL, et al. European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017Oct30;18(1):108. Erratum in: J Headache Pain. 2018 Sep 10;19(1):81.PMID: 29086160; PMCID: PMC5662520.
   PubMed Web of Science ®Google Scholar
• Luciani M, Negro A, Spuntarelli V, et al. Evaluating and managing severe headache in the emergency department. Expert Rev Neurother. 2021Mar;21(3):277–285. Epub 2021 Jan 4. PMID: 33297780.
   PubMed Web of Science ®Google Scholar
• Ali MW, Musami UB, Sa’ad FK, et al. Profile of migraine patients in a developing country: a multicentre study. SN Compr Clin Med. 2020;2(8):1153–1157.
   Google Scholar
• Oö Y, Uluduz D, Özge A, et al. Phenotypic features of chronic migraine. J Headache Pain. 2016;17(1):26. Epub 2016 Mar 15. PMID: 26975363; PMCID: PMC4791410.
   PubMed Web of Science ®Google Scholar
• Caponnetto V, Deodato M, Robotti M, et al. European Headache Federation School of Advanced Studies (EHF-SAS). Comorbidities of primary headache disorders: a literature review with meta-analysis. J Headache Pain. 2021Jul14;22(1):71. PMID: 34261435; PMCID: PMC8278743.
   PubMed Web of Science ®Google Scholar
• Patel UK, Malik P, Sheth R, et al. Fibromyalgia and myositis linked to higher burden and disability in patients with migraine. J hr Clin Med. 2019; 1: 882–890.
   Google Scholar
• García-Marín LM, Campos AI, Martin NG, et al. Phenome-wide analysis highlights putative causal relationships between self-reported migraine and other complex traits. J Headache Pain. 2021Jul8;22(1):66. PMID: 34238214; PMCID: PMC8268337.
   PubMed Web of Science ®Google Scholar
• Martelletti P, Luciani M, Spuntarelli V, et al. Deprescribing in migraine. Expert Opin Drug Saf. 2021 Jun;20(6):623–625. Epub 2021 Mar 25. PMID: 33749470.
   PubMed Web of Science ®Google Scholar